Strengthen Technical Documentation Readiness for EU MDR Compliance
About this webinar
The EU Medical Device Regulation (MDR) transition deadlines for legacy Class II devices are approaching. Certain implantable Class IIb devices have until December 31, 2027, while eligible Class IIa and other Class IIb devices have until December 31, 2028, provided the applicable transition conditions are maintained. For many manufacturers, technical documentation is where timelines slip, as files may be returned by notified bodies due to gaps, inconsistencies and outdated content. This webinar explores strategies to improve technical documentation readiness, reduce compliance risks and prepare for EU MDR requirements.
Attendees will learn how to assess technical documentation readiness against EU MDR Annex II and III, find gaps before submission and keep documentation current as designs and post-market data change, rather than rebuilding technical files for every review cycle.
The featured speakers will also explore how teams are applying automation and AI to technical documentation, helping streamline file preparation and ongoing maintenance. These approaches can support earlier identification of documentation gaps and reduce manual assembly efforts while ensuring regulatory experts retain oversight of critical decisions.
Register for this webinar to learn how to strengthen technical documentation, address EU MDR compliance gaps and prepare more complete submissions for notified body review.
Who should attend
- Chief Quality Officers
- Heads and VPs of Regulatory Affairs
- Regulatory Affairs Directors and Managers
- Heads and VPs of Quality Assurance
- Quality Assurance Directors
- Quality and Regulatory Compliance Directors
- Technical Documentation and Technical File Managers
- Heads of Product Development and R&D Directors at Class II device companies
What you will learn
- Navigate EU MDR deadlines: Understand how the 2027 and 2028 dates apply to Class II devices and which conditions must be maintained
- Assess technical documentation readiness: Identify gaps against Annex II and III before notified body submission
- Maintain current technical files: Establish processes to track documentation updates as device designs and post-market data evolve
- Apply automation and AI: Learn how these technologies can streamline documentation workflows and identify compliance gaps while maintaining expert oversight
Featured Speaker
Sumatha Kondabolu, MSc
Sumatha Kondabolu brings over 23 years of global quality and regulatory expertise across the pharmaceutical and medical device industries. A global speaker and international standards leader, she specializes in quality systems, regulatory compliance, AI governance and emerging technologies, translating complex global requirements into practical strategies for organizations.
Sumatha has built and managed quality management systems meeting the requirements of FDA QSR, Canada’s Medical Devices Regulations, NIOSH, MDSAP, COFEPRIS and the EU MDR and IVDR, as well as pre-clinical and clinical frameworks. She has supported organizations in establishing robust quality systems aligned with global standards and successfully navigating ISO and regulatory audits.
Sumatha holds a Bachelor of Pharmacy, a Master’s in Chemistry and an Advanced Certificate in Quality Assurance Management. She is a certified auditor for ISO 13485, ISO 27001, ISO 27701, ISO 42001, ISO 22716, ISO 17025, ISO 9001 and IATF 16949.
Beyond her professional role, Sumatha contributes to international standards development and professional communities. She serves as Chair of CSA Z289 and Chair of the Canadian Mirror Committee for ISO/TC 210, focused on quality management and related general aspects for products for health purposes, including medical devices. She also contributes as an expert to ISO/IEC JTC 1/SC 27 in information security, cybersecurity, privacy protection and IEC TC 65/SC 65.
She is also Co-Chair of the International Society of Pharmacovigilance (ISoP) Medical Devices Special Interest Group and Vice-Chair of the RAPS Quebec Local Networking Group. As an international speaker, she regularly contributes to global discussions on medical devices, quality and regulatory science, artificial intelligence, digital health and emerging technologies.
Partner for this event
Qualio
Founded in 2012, Qualio is the agentic quality and regulatory compliance platform for life sciences. It unifies quality management, product lifecycle, and regulatory intelligence in a single system, replacing fragmented point tools, manual workflows, and reactive audit prep. Teams use Qualio to accelerate regulatory milestones and product development velocity, while reducing the risk of costly findings and recalls. Qualio is ISO 27001-, 42001-, 9001-, and 27701-certified, reflecting our commitment to the highest standards of security, quality, and privacy.